The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Genome Editing
(Jan 2023)
Corrigendum: CRISPR nuclease off-target activity and mitigation strategies
Beeke Wienert,
M. Kyle Cromer,
M. Kyle Cromer,
M. Kyle Cromer
Affiliations
Beeke Wienert
Graphite Bio, Inc., South San Francisco, CA, United States
M. Kyle Cromer
Department of Surgery, University of California, San Francisco, San Francisco, CA, United States
M. Kyle Cromer
Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, United States
M. Kyle Cromer
Eli and Edythe Broad Center for Regeneration Medicine, University of California, San Francisco, San Francisco, CA, United States
DOI
https://doi.org/10.3389/fgeed.2022.1112956
Journal volume & issue
Vol. 4
Abstract
Read online
No abstracts available.
Keywords
gene therapy
off-target activity
in vivo delivery
genome editing
CRISPR/Cas9
next-generating sequencing
WeChat QR code
Close